Tumor-specific recognition molecules

US9345794B2 · kind B2 · utility

Assignee

• Glycotype GmbH · DE

Inventors

• Steffen Goletz · Berlin, DE
• Antje Danielczyk · Kolberg, DE
• Uwe Karsten · Berlin, DE
• Peter Ravn · Hadsten, DK
• Renate Stahn · Berlin, DE
• Peter Astrup Christensen · Vejen, DK

Key dates

• Filing date: Dec 10, 2013
• Grant date: May 24, 2016
• Expiry date: Dec 10, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.